Skip to content

Safety & Adverse Events

Main result

0

Serious adverse events

BMJ · MacPherson et al. · 2001 · 574 participants

The York acupuncture safety study: prospective survey of 34 000 treatments by traditional acupuncturists

Strong
  • 1.3 per 1000

    Minor adverse events

  • 15 %

    Mild transient reactions

Study design sheet

  • Prospective Study
  • n=34,407 treatments
  • High Impact - BMJ
Participants
574

n = 574; median of studies with the same design: 96

Duration

4 weeks

4 weeks of data collection

Groups
  • Participating acupuncturists (574)Prospective documentation of adverse events
OBJECTIVE
Assess the safety of acupuncture by documenting types and frequency of adverse events
WHO
574 professional acupuncturists in the United Kingdom
POINTS
Traditional acupuncture — points not specified
Results in numbers
  • 0Serious adverse events
  • 1.3 per 1000Minor adverse events
  • 15 %Mild transient reactions
  • 86 %Aggravation followed by improvement
Outcome comparison
  • Adverse event rate per 1000 treatments
    • Minor events: 1.3 of 10

What does this mean for you?

This large study showed that acupuncture is very safe when practiced by qualified professionals. There were no serious events across more than 34,000 treatments, and minor side effects were rare and temporary.

Article summary

Plain-language narrative summary

The York Safety Study represents a landmark in research on the safety of acupuncture, being one of the largest prospective surveys ever conducted on adverse events in this practice. Carried out in the United Kingdom in 2000, the study involved 574 professional acupuncturists who systematically documented all adverse events over a four-week period, covering 34,407 acupuncture treatments. The primary objective was to establish reliable data on the safety of traditional acupuncture, a crucial issue for the integration of this practice into conventional medicine. The methodology used was rigorous, employing a prospective postal audit system in which practitioners recorded details of any adverse event considered 'significant,' including unusual or dangerous events or events causing significant inconvenience to patients.

Participants represented 31% of all professional acupuncturists registered with the British Acupuncture Council, with a demographic distribution representative of the total practitioner population. The results were exceptionally reassuring regarding the safety of acupuncture. No serious adverse events were reported — defined as those requiring hospitalization, leading to permanent disability, or resulting in death. With 95% confidence, this establishes a maximum rate of serious events of 1.1 per 10,000 treatments.

Forty-three minor adverse events were documented, representing a rate of 1.3 per 1,000 treatments. The most common events included severe nausea and fainting (12 cases), unexpected and prolonged aggravation of existing symptoms (7 cases), and prolonged local pain with bruising (5 cases). Notably, three events were classified as avoidable practitioner errors, including forgotten needles and moxibustion burns. The study also documented mild transient reactions in 15% of treatments, many of which are considered positive signs of therapeutic response.

These included a sensation of relaxation (11.9% of cases), a sensation of energy (6.6%), and mild bruising at the puncture site (1.7%). Particularly interesting was the observation that aggravation of existing symptoms was recorded after 966 treatments (2.8%), and 86% of these were followed by improvement, suggesting the phenomenon known as 'healing crisis.' The clinical implications of this study are significant for patients, practitioners, and health policy makers. According to the authors, comparing this adverse event rate with that of drugs routinely prescribed in primary care suggests that acupuncture is a relatively safe form of treatment. For patients, these data offer reassurance that traditional acupuncture is safe, with minimal risks of serious events.

Limitations of the study include the potential self-reporting bias, in which practitioners may underreport adverse events, and the relatively short four-week observation period. In addition, the study focused only on professionally registered acupuncturists, not covering unregulated practitioners. Representativeness may have been affected by the voluntary participation of only one-third of eligible practitioners. The authors regard the data as important evidence on public health and safety, even given the potential bias of self-reporting, and note that further research measuring patients' experience of adverse events is merited.

Strengths

  • Large prospective sample: 34,407 acupuncture treatments documented
  • Rigorous methodology with prospective audit
  • Representative practitioner population
  • Clear definitions of adverse events

Limitations

  • Potential self-reporting bias by practitioners
  • Observation period limited to 4 weeks
  • Only one-third of practitioners participated
  • Did not include unregulated practitioners
Dr. Marcus Yu Bin Pai

Expert Commentary

Clinical Relevance

The safety profile documented in this work has direct impact on clinical decision-making, especially when we evaluate acupuncture as an adjuvant therapeutic option in patients with comorbidities, polypharmacy, or relative contraindications to anti-inflammatories and opioids. Across 34,407 prospectively audited treatments, the absence of serious adverse events — with an upper confidence limit of 1.1 per 10,000 treatments — places acupuncture in a favorable position relative to various pharmacologic interventions in primary care. For the physician managing chronic musculoskeletal pain, fibromyalgia, or headache, these data support the indication with less reticence in vulnerable populations: older adults, pregnant women in the second and third trimesters, patients with NSAID-related gastropathy, and those with renal insufficiency who cannot tolerate conventional analgesics. The minor event rate of 1.3 per 1,000 treatments is concrete information for informed consent, making the pre-procedure conversation more objective and less speculative.

Notable Findings

The finding that deserves attention is the dissociation between transient reactions — present in 15% of treatments — and adverse events proper. Deep relaxation, increased energy sensation, and local ecchymoses are part of an expected physiologic response, not an alarm sign, and the study makes this distinction operational. Equally relevant is the dynamic of transient symptom aggravation: aggravation occurred after 2.8% of treatments, and 86% of these cases evolved with subsequent improvement. This pattern, which often generates anxiety in the patient and doubt in the attending physician, here receives a solid epidemiologic basis. The three events classified as avoidable errors — forgotten needles and moxibustion burns — reinforce that the documented residual risk is predominantly procedural in nature and, therefore, mitigable through protocol, training, and post-session checklist.

From My Experience

In my practice at the musculoskeletal pain clinic, the safety profile described here is consistent with what I have observed over decades. The transient aggravation followed by improvement is a phenomenon I have learned to verbally anticipate with the patient before the first session — when I do this, the rate of early dropout drops noticeably. I typically see measurable clinical response between the third and fifth session in chronic low back pain and tension cervical pain; patients with myofascial syndrome with active trigger points tend to respond even sooner. For maintenance, the pattern I have observed throughout my career is 8 to 12 initial sessions, with reassessment for progressive spacing. I routinely combine with supervised kinesiotherapy and, when relevant, with dry needling of trigger points in the same session. I do not indicate acupuncture alone in patients with severe decompensated anxiety disorder — the expectation of initial aggravation can precipitate dropout or catastrophizing.

Dr. Marcus Yu Bin Pai · MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture.

Indexed scientific article

This study is indexed in an international scientific database. Check your institutional access to obtain the full article.

Scientific review

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.

  • Strong
  • Moderate
  • Limited
  • Weak
19801990200020102020
This study among the Library’s studiesEach dot is a study: left to right, the publication year; top to bottom, the study design, from meta-analyses to preclinical work; colour and shape give the level of evidence. Highlighted: the Safety & Adverse Events studies.
See the numbers: This study among the Library’s studies
Study designSafety & Adverse EventsAll studies
Meta-analysis · Systematic Review12387
RCT5224
Clinical Guideline15
Observational738
Case Series17
Narrative Review2155
Preclinical / Animal06
Other7203
See the Safety & Adverse Events studies in the Library

Related articles

Based on this article’s categories

  1. Li et al. · CMAJ · 2012

    • Headache & Migraine
    • Safety & Adverse Events
  2. Witt et al. · Acupuncture in Medicine · 2006

    • Chronic Pain
    • Safety & Adverse Events
  3. dos Santos Maciel et al. · BMC Complementary and Alternative Medicine · 2016

    • Clinical Trial Methodology
    • Safety & Adverse Events
  4. Duan et al. · BMJ Evidence-Based Medicine · 2026

    • Clinical Trial Methodology
    • Safety & Adverse Events
    • Systematic Reviews & Meta-Analyses